01—Abstract
Summary
Summary of the 10-Q filed April 26, 2024. Cited figures are marked; the original filing is the authoritative source.
Colgate-Palmolive Company reported robust financial results for the first quarter of 2024, demonstrating strong top-line growth and improved profitability.
Net sales increased by 6.2%a year-over-year, driven by both volume growth and significant price increases, with organic sales growing by 9.8%. This growth was broad-based across its core Oral, Personal and Home Care segment and the Pet Nutrition segment. The company also showcased enhanced profitability, with gross profit margin expanding to 60.0% from 56.9% in the prior year, attributed to higher pricing and cost savings initiatives.
Operating profit saw a substantial 15% increase, reflecting improved operational efficiencies and strategic pricing actions. Diluted Earnings Per Share (EPS) rose to $0.83b, up significantly from $0.45 in the first quarter of 2023, highlighting the company's ability to translate sales growth into enhanced shareholder returns. The company also announced an increase in its quarterly common stock dividend, signaling confidence in its financial health and commitment to returning value to shareholders.
02—Key points
Key Highlights
- Net sales increased by 6.2% to $5,065 million in Q1 2024 compared to Q1 2023, driven by 1.3% volume growth and 8.5% net selling price increases.
- Organic sales (excluding foreign exchange, acquisitions, and divestments) grew by a strong 9.8% year-over-year.
- Gross profit margin improved significantly to 60.0% from 56.9% in the prior year, supported by pricing actions and cost savings initiatives.
- Operating profit rose by 15% to $1,047 million, indicating effective cost management and operational leverage.
- Diluted Earnings Per Share (EPS) increased to $0.83 from $0.45 in the prior year's quarter.
- The company announced an increase in its quarterly common stock dividend to $0.50 per share, effective in the second quarter of 2024.
- Hill's Pet Nutrition segment net sales grew 3.9%, with organic sales increasing by 4.2%, demonstrating continued strength in this division despite a slight volume decline.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q1 FY2024, Colgate-Palmolive kept $0.13.
- Revenue$5.07B100.0%
- Cost of revenue−$2.03B40.0%
- Gross profit$3.04B60.0%
- Operating costs−$1.99B39.3%
- Operating income$1.05B20.7%
- Interest, other & tax−$364.0M7.2%
- Net income$683.0M13.5%
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2024filed April 26, 2024Financial Statements
Q1 FY2024 against Q1 FY2023
| Line item | Q1 FY2024Q1 FY2023 | Change |
|---|---|---|
| Revenue | $5.07B$4.77B | +6.2% |
| Cost of Revenue | $2.03B$2.06B | −1.6% |
| Gross Profit | $3.04B$2.71B | +12.1% |
| SG&A Expenses | $1.92B$1.76B | +9.0% |
| Operating Income | $1.05B$909.00M | +15.2% |
| Net Income | $683.00M$372.00M | +83.6% |
| EPS (Basic) | $0.83$0.45 | +84.4% |
| EPS (Diluted) | $0.83$0.45 | +84.4% |
| Shares Outstanding (Basic) | 822.80M831.40M | −1.0% |
| Shares Outstanding (Diluted) | 825.90M833.00M | −0.9% |
05—Questions
Frequently Asked Questions
What drove the significant increase in Net Sales?
Net sales increased by 6.2% year-over-year primarily due to a combination of volume growth of 1.3% and net selling price increases of 8.5%. This indicates that Colgate-Palmolive effectively passed on costs and potentially gained market share through product desirability.
How did the company manage its costs and improve profitability?
Profitability improved significantly with a 310 basis point increase in gross profit margin to 60.0%. This was driven by higher pricing and 250 basis points of cost savings from the Company's 'funding-the-growth' initiatives, which more than offset the impact of higher raw and packaging material costs.
What is the outlook for the company given the current economic environment?
Colgate-Palmolive anticipates continued challenging global macroeconomic, political, and market conditions, including inflation and higher interest rates, which could impact consumer demand and purchasing patterns. The company plans to continue implementing pricing strategies and cost-saving initiatives, such as the 2022 Global Productivity Initiative, to mitigate these effects and maintain profitability.
Are there any significant legal or contingent liabilities that investors should be aware of?
The company is involved in various legal proceedings, including tax and civil proceedings in Brazil, competition law matters, talcum powder litigation, and an ERISA litigation matter. While management believes the ultimate resolution of these matters will not have a material adverse effect on the consolidated financial position, there is a disclosure of a range of reasonably possible losses ($0 to approximately $300 million) in excess of accrued liabilities for certain matters. The ERISA litigation matter resulted in a charge of $267 million in Q1 2023 and ongoing developments in March 2024 could lead to further appeals.
06—Continue